Mark Mogler

671 total citations
20 papers, 495 citations indexed

About

Mark Mogler is a scholar working on Infectious Diseases, Animal Science and Zoology and Agronomy and Crop Science. According to data from OpenAlex, Mark Mogler has authored 20 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Animal Science and Zoology and 7 papers in Agronomy and Crop Science. Recurrent topics in Mark Mogler's work include Viral gastroenteritis research and epidemiology (9 papers), Animal Virus Infections Studies (9 papers) and Animal Disease Management and Epidemiology (7 papers). Mark Mogler is often cited by papers focused on Viral gastroenteritis research and epidemiology (9 papers), Animal Virus Infections Studies (9 papers) and Animal Disease Management and Epidemiology (7 papers). Mark Mogler collaborates with scholars based in United States, Netherlands and Switzerland. Mark Mogler's co-authors include Kurt I. Kamrud, D. L. Harris, Alan T. Loynachan, Raymond R. R. Rowland, Tanja Opriessnig, Chao‐Ting Xiao, Priscilla F. Gerber, Patrick G. Halbur, John Dustin Loy and Luis G. Giménez‐Lirola and has published in prestigious journals such as PLoS ONE, Journal of General Virology and Vaccine.

In The Last Decade

Mark Mogler

18 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Mogler United States 13 235 224 150 126 116 20 495
Ganesh Kondabattula India 12 150 0.6× 144 0.6× 121 0.8× 97 0.8× 60 0.5× 26 427
Melanie Prarat United States 11 178 0.8× 132 0.6× 135 0.9× 88 0.7× 76 0.7× 15 439
Semmannan Kalaiyarasu India 12 152 0.6× 133 0.6× 63 0.4× 101 0.8× 221 1.9× 37 504
Seong-In Lim South Korea 14 197 0.8× 252 1.1× 237 1.6× 79 0.6× 113 1.0× 42 493
Tirumala Bharani K. Settypalli Austria 14 197 0.8× 117 0.5× 73 0.5× 167 1.3× 245 2.1× 48 539
María Gabriela Echeverría Argentina 13 114 0.5× 96 0.4× 143 1.0× 72 0.6× 224 1.9× 72 499
Mikhayil Hakhverdyan Sweden 16 141 0.6× 193 0.9× 151 1.0× 74 0.6× 129 1.1× 27 499
Encheng Sun China 14 331 1.4× 314 1.4× 99 0.7× 277 2.2× 122 1.1× 46 630
P. Saravanan India 15 357 1.5× 322 1.4× 125 0.8× 234 1.9× 455 3.9× 39 753
Masoud Reza Seyfi Abad Shapouri Iran 9 62 0.3× 275 1.2× 202 1.3× 78 0.6× 68 0.6× 66 395

Countries citing papers authored by Mark Mogler

Since Specialization
Citations

This map shows the geographic impact of Mark Mogler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mogler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mogler more than expected).

Fields of papers citing papers by Mark Mogler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mogler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mogler. The network helps show where Mark Mogler may publish in the future.

Co-authorship network of co-authors of Mark Mogler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Mogler. A scholar is included among the top collaborators of Mark Mogler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Mogler. Mark Mogler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mogler, Mark, et al.. (2024). Efficacy and Safety in Dogs Following Administration of an Alphavirus RNA Particle Canine Influenza H3N2 Vaccine. Vaccines. 12(10). 1138–1138. 1 indexed citations
3.
4.
Welch, Michael, Karen Krueger, Jianqiang Zhang, et al.. (2022). Detection of porcine parainfluenza virus type-1 antibody in swine serum using whole-virus ELISA, indirect fluorescence antibody and virus neutralizing assays. BMC Veterinary Research. 18(1). 110–110. 8 indexed citations
5.
Anderson, Tavis K., Pravina Kitikoon, J. Brian Kimble, et al.. (2022). Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease. Vaccine. 40(38). 5569–5578. 12 indexed citations
6.
Phanse, Yashdeep, Kathleen A. Ross, Mark Mogler, et al.. (2022). RNA Nanovaccine Protects against White Spot Syndrome Virus in Shrimp. Vaccines. 10(9). 1428–1428. 21 indexed citations
7.
Langereis, Martijn A., Irina C. Albulescu, Judith Stammen‐Vogelzangs, et al.. (2021). An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats. npj Vaccines. 6(1). 122–122. 20 indexed citations
8.
Murgia, Maria V., Mark Mogler, Diane Green, et al.. (2018). Evaluation of an African swine fever (ASF) vaccine strategy incorporating priming with an alphavirus-expressed antigen followed by boosting with attenuated ASF virus. Archives of Virology. 164(2). 359–370. 54 indexed citations
9.
Giménez‐Lirola, Luis G., Lina Mur, Belén Rivera, et al.. (2016). Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA. PLoS ONE. 11(9). e0161230–e0161230. 82 indexed citations
10.
Nahampun, Hartinio Natalia, Brad T. Bosworth, Joan E. Cunnick, Mark Mogler, & Kan Wang. (2015). Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice. Plant Cell Reports. 34(6). 969–980. 22 indexed citations
11.
Blitvich, Bradley J., et al.. (2015). Characterization of newly revealed sequences in the infectious myonecrosis virus genome in Litopenaeus vannamei. Journal of General Virology. 96(7). 1821–1829. 7 indexed citations
12.
Mogler, Mark & Kurt I. Kamrud. (2014). RNA-based viral vectors. Expert Review of Vaccines. 14(2). 283–312. 36 indexed citations
13.
Loy, John Dustin, et al.. (2013). Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle. Virology Journal. 10(1). 35–35. 21 indexed citations
14.
Opriessnig, Tanja, Priscilla F. Gerber, Chao‐Ting Xiao, Mark Mogler, & Patrick G. Halbur. (2013). A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain. Vaccine. 32(2). 230–237. 54 indexed citations
15.
Mogler, Mark, et al.. (2013). Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus. Veterinary Record. 173(14). 344–344. 28 indexed citations
16.
Loynachan, Alan T., et al.. (2012). Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine. 30(11). 1944–1950. 59 indexed citations
17.
Loy, John Dustin, Mark Mogler, Bruce H. Janke, et al.. (2012). dsRNA provides sequence-dependent protection against infectious myonecrosis virus in Litopenaeus vannamei. Journal of General Virology. 93(4). 880–888. 28 indexed citations
18.
Kamrud, Kurt I., Mark Mogler, Alan T. Loynachan, et al.. (2009). Rapid Development of an Efficacious Swine Vaccine for Novel H1N1. PLoS Currents. 1. RRN1123–RRN1123. 24 indexed citations
19.
Mogler, Mark, et al.. (2009). Comparison of Enrichment Procedures for Shiga Toxin–Producing Escherichia coli in Wastes from Commercial Swine Farms. Journal of Food Protection. 72(9). 1982–1986. 10 indexed citations
20.
Mogler, Mark, et al.. (2008). Control and eventual elimination of PRRSV via development of an effective DIVA vaccine. University of Minnesota Digital Conservancy (University of Minnesota). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ganesh Kondabattula Breakdown of academic impact, for papers by Melanie Prarat Breakdown of academic impact, for papers by Semmannan Kalaiyarasu Breakdown of academic impact, for papers by Seong-In Lim Breakdown of academic impact, for papers by Tirumala Bharani K. Settypalli Breakdown of academic impact, for papers by María Gabriela Echeverría Breakdown of academic impact, for papers by Mikhayil Hakhverdyan Breakdown of academic impact, for papers by Encheng Sun Breakdown of academic impact, for papers by P. Saravanan Breakdown of academic impact, for papers by Masoud Reza Seyfi Abad Shapouri
Rankless by CCL
2026